Search results for "COVID-19"

We have a responsibility to support the critical infrastructure industries in the fight against COVID-19 as they continue providing the essentials people need.

Every day within Emerson, our teams and locations are united around a common purpose of improving the quality of lives around the world. As COVID-19 evolves and the threat of Coronavirus becomes a daily concern, our commitment to advancing human health, comfort and safety and to helping keep food fresh and safe takes on new, more critical meaning.

Turnarounds are becoming even trickier due to the impact of supply chain problems, staff shortages, lack of contractors and other COVID-19-related issues.

Fluid Power Journal details how Emerson has faced the challenges brought on by the COVID-19 pandemic to business, community involvement and personnel. A critical ongoing focus is keeping customers and employees safe while servicing customer’s needs.

In this feature-length article, they cover in-depth the impact the pandemic has had on Emerson and how Mr. Farr’s leadership – and limitations – are leading the company through.

Design World Online details how Emerson is stepping up production of Branson Ultrasonic Welders due to the critical need for non-woven protective medical gear for first responders against COVID-19.

Emerson helps pharmaceutical companies, hospitals and other healthcare organizations fast-track research, development and delivery of lifesaving COVID-19 treatments.

Emerson is proud to have the strongest network of Automation professionals in the industry and in being a trusted partner to ensure the safe and profitable operation of your business.

Today the process is largely manual, but that is changing. The invention, rapid manufacturing and distribution of the COVID-19 vaccine demonstrates exactly how fast the life sciences treatment development pipeline can move when the right factors are in play. Biopharmaceutical treatments commonly take upwards of 15 years to develop, but the COVID vaccine was created and manufactured in only eight months.

This is a time where our essential and critical workers are being relied upon to provide services we expect every day, and we need to do everything we can to support them.

Emerson announced it will support customers during the worldwide COVID-19 outbreak by offering free online courses through the remainder of 2020. The most up-to-date information on Emerson products including Copeland™ compressors for air conditioning and refrigeration applications as well as refrigeration equipment will be available online.

Emerson plant maintenance and reliability experts Brian Dubaskas and Navin Rajashekar recently shared lessons learned because of COVID in an article on Automation.com.

Emerson’s Director of Life Sciences Consulting Michalle Adkins shares her thoughts with PharmTech on how digital tools speed qualification for pharma manufacturers.

When you need high-volume PPE production, they turn to Branson technology for high process speeds and repeatable output

Emerson has acquired Fluxa, a leader in the life sciences industry that uses software and modern technology architectures to accelerate the speed to market for new therapies, drugs and vaccines.

In the September 2022 issue of Processing magazine, Emerson's VP of Life Sciences, Kristel Biehler shares how new software and technologies and strategies are breaking down silos to user in a new era of fast, modular life sciences manufacturing.

Life science manufacturers are looking for new and innovative ways to analyze data during the manufacturing process

We are helping the world’s largest companies reach their sustainability goals and optimize operations with novel automation technologies.

Emerson Survey states that hands-on learning experience is critical for STEM education, but is a challenge in remote learning environments.

Emerson today announced that Mike Baughman, vice President, controller and chief accounting Officer, has been promoted to executive vice president and chief financial officer, effective May 10. He succeeds Frank Dellaquila, who will be retiring after 32 years with the company.